Glaukos Corp Stock Beta

GKOS Stock

USD 142.94 1.06 0.74%

Glaukos Corp fundamentals help investors to digest information that contributes to Glaukos Corp's financial success or failures. It also enables traders to predict the movement of Glaukos Stock. The fundamental analysis module provides a way to measure Glaukos Corp's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Glaukos Corp stock.

Other Current Liab Total Assets

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Glaukos Corp Company Beta Analysis

Glaukos Corp's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.

Beta

Covariance

Variance

More About Beta | All Equity Analysis

Current Glaukos Corp Beta

1.03

Most of Glaukos Corp's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Glaukos Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Glaukos Beta Driver Correlations

Understanding the fundamental principles of building solid financial models for Glaukos Corp is extremely important. It helps to project a fair market value of Glaukos Stock properly, considering its historical fundamentals such as Beta. Since Glaukos Corp's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Glaukos Corp's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Glaukos Corp's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Common Stock	Long Term Debt	Short Term Investments	Treasury Stock	Intangible Assets	Property Plant Equipment	Net Tangible Assets	Short Term Debt	Current Deferred Revenue	Long Term Debt Total	Capital Surpluse	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.95	0.8	-0.72	0.66	0.95	0.81	0.97	0.84	0.87	0.92	0.34	0.84	0.76	0.84	-0.73	-0.3	0.72	0.98	0.98	0.93	0.91
Total Stockholder Equity	0.95		0.64	-0.59	0.55	0.95	0.63	0.93	0.87	0.8	0.88	0.23	0.86	0.63	0.88	-0.78	-0.46	0.76	0.91	0.92	0.84	0.82
Net Debt	0.8	0.64		-0.93	0.82	0.7	0.97	0.8	0.6	0.86	0.78	0.61	0.55	0.93	0.66	-0.53	-0.01	0.58	0.84	0.87	0.9	0.94
Retained Earnings	-0.72	-0.59	-0.93		-0.93	-0.71	-0.9	-0.74	-0.67	-0.85	-0.7	-0.78	-0.53	-0.88	-0.75	0.59	0.18	-0.68	-0.79	-0.77	-0.77	-0.9
Accounts Payable	0.66	0.55	0.82	-0.93		0.7	0.82	0.67	0.67	0.84	0.6	0.67	0.55	0.82	0.73	-0.6	-0.26	0.7	0.72	0.69	0.66	0.84
Net Receivables	0.95	0.95	0.7	-0.71	0.7		0.72	0.94	0.92	0.85	0.88	0.4	0.86	0.69	0.91	-0.85	-0.53	0.85	0.94	0.91	0.82	0.85
Total Liab	0.81	0.63	0.97	-0.9	0.82	0.72		0.79	0.58	0.86	0.75	0.57	0.59	0.89	0.67	-0.51	-0.01	0.56	0.85	0.87	0.89	0.93
Total Current Assets	0.97	0.93	0.8	-0.74	0.67	0.94	0.79		0.89	0.85	0.98	0.32	0.83	0.77	0.82	-0.81	-0.36	0.78	0.93	0.94	0.94	0.86
Common Stock	0.84	0.87	0.6	-0.67	0.67	0.92	0.58	0.89		0.75	0.87	0.33	0.76	0.64	0.86	-0.92	-0.64	0.89	0.79	0.76	0.72	0.72
Long Term Debt	0.87	0.8	0.86	-0.85	0.84	0.85	0.86	0.85	0.75		0.8	0.52	0.87	0.87	0.81	-0.68	-0.3	0.75	0.89	0.9	0.86	0.93
Short Term Investments	0.92	0.88	0.78	-0.7	0.6	0.88	0.75	0.98	0.87	0.8		0.26	0.78	0.75	0.76	-0.81	-0.36	0.77	0.87	0.89	0.94	0.81
Treasury Stock	0.34	0.23	0.61	-0.78	0.67	0.4	0.57	0.32	0.33	0.52	0.26		0.22	0.56	0.48	-0.23	-0.13	0.4	0.5	0.39	0.34	0.59
Intangible Assets	0.84	0.86	0.55	-0.53	0.55	0.86	0.59	0.83	0.76	0.87	0.78	0.22		0.58	0.77	-0.69	-0.45	0.71	0.81	0.81	0.74	0.72
Property Plant Equipment	0.76	0.63	0.93	-0.88	0.82	0.69	0.89	0.77	0.64	0.87	0.75	0.56	0.58		0.58	-0.58	-0.15	0.64	0.78	0.8	0.82	0.88
Net Tangible Assets	0.84	0.88	0.66	-0.75	0.73	0.91	0.67	0.82	0.86	0.81	0.76	0.48	0.77	0.58		-0.78	-0.53	0.83	0.85	0.84	0.74	0.84
Short Term Debt	-0.73	-0.78	-0.53	0.59	-0.6	-0.85	-0.51	-0.81	-0.92	-0.68	-0.81	-0.23	-0.69	-0.58	-0.78		0.78	-0.97	-0.68	-0.67	-0.65	-0.63
Current Deferred Revenue	-0.3	-0.46	-0.01	0.18	-0.26	-0.53	-0.01	-0.36	-0.64	-0.3	-0.36	-0.13	-0.45	-0.15	-0.53	0.78		-0.81	-0.25	-0.21	-0.12	-0.19
Long Term Debt Total	0.72	0.76	0.58	-0.68	0.7	0.85	0.56	0.78	0.89	0.75	0.77	0.4	0.71	0.64	0.83	-0.97	-0.81		0.7	0.68	0.64	0.69
Capital Surpluse	0.98	0.91	0.84	-0.79	0.72	0.94	0.85	0.93	0.79	0.89	0.87	0.5	0.81	0.78	0.85	-0.68	-0.25	0.7		0.97	0.91	0.94
Net Invested Capital	0.98	0.92	0.87	-0.77	0.69	0.91	0.87	0.94	0.76	0.9	0.89	0.39	0.81	0.8	0.84	-0.67	-0.21	0.68	0.97		0.96	0.96
Net Working Capital	0.93	0.84	0.9	-0.77	0.66	0.82	0.89	0.94	0.72	0.86	0.94	0.34	0.74	0.82	0.74	-0.65	-0.12	0.64	0.91	0.96		0.91
Capital Stock	0.91	0.82	0.94	-0.9	0.84	0.85	0.93	0.86	0.72	0.93	0.81	0.59	0.72	0.88	0.84	-0.63	-0.19	0.69	0.94	0.96	0.91

Click cells to compare fundamentals

In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.

Competition

Predict Glaukos Corp

In accordance with the recently published financial statements, Glaukos Corp has a Beta of 1.028. This is 19.53% higher than that of the Health Care Equipment & Supplies sector and about the same as Health Care (which currently averages 1.04) industry. The beta for all United States stocks is notably lower than that of the firm.

Glaukos Beta Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Glaukos Corp's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Glaukos Corp could also be used in its relative valuation, which is a method of valuing Glaukos Corp by comparing valuation metrics of similar companies.

Glaukos Corp is currently under evaluation in beta category among its peers.

Glaukos Corp ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Glaukos Corp's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Glaukos Corp's managers, analysts, and investors.

Environmental

Governance

Social

Glaukos Corp Institutional Holders

Institutional Holdings refers to the ownership stake in Glaukos Corp that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Glaukos Corp's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Glaukos Corp's value.

		Shares
Morgan Stanley - Brokerage Accounts	2024-06-30	1.2 M
Geode Capital Management, Llc	2024-09-30	1.2 M
Fred Alger Management, Llc	2024-09-30	1.1 M
Driehaus Capital Management Llc	2024-06-30	803.6 K
Artisan Partners Limited Partnership	2024-09-30	795.2 K
Gilder Gagnon Howe & Co Llc	2024-09-30	658.6 K
Charles Schwab Investment Management Inc	2024-09-30	641.8 K
Loomis, Sayles & Company Lp	2024-06-30	554.2 K
Wellington Management Company Llp	2024-06-30	553.5 K
Blackrock Inc	2024-06-30	8 M
Fmr Inc	2024-09-30	6.6 M

Glaukos Corp returns are very sensitive to returns on the market. As the market goes up or down, Glaukos Corp is expected to follow.

Glaukos Fundamentals

	Return On Equity	-0.26
	Return On Asset	-0.0774
	Profit Margin	(0.42) %
	Operating Margin	(0.26) %
	Current Valuation	7.83 B
	Shares Outstanding	55.14 M
	Shares Owned By Insiders	3.19 %
	Shares Owned By Institutions	96.81 %
	Number Of Shares Shorted	2.64 M
	Price To Earning	94.70 X
	Price To Book	11.88 X
	Price To Sales	22.03 X
	Revenue	314.71 M
	Gross Profit	213.88 M
	EBITDA	(82.12 M)
	Net Income	(134.66 M)
	Cash And Equivalents	391.19 M
	Cash Per Share	8.22 X
	Total Debt	383.74 M
	Debt To Equity	0.68 %
	Current Ratio	6.78 X
	Book Value Per Share	12.13 X
	Cash Flow From Operations	(57.76 M)
	Short Ratio	6.00 X
	Earnings Per Share	(2.92) X
	Price To Earnings To Growth	1.64 X
	Target Price	141.67
	Number Of Employees	907
	Beta	1.03
	Market Capitalization	7.94 B
	Total Asset	940.41 M
	Retained Earnings	(599.07 M)
	Working Capital	321.45 M
	Current Asset	104.14 M
	Current Liabilities	20.36 M
	Net Asset	940.41 M

About Glaukos Corp Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Glaukos Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Glaukos Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Glaukos Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Glaukos Stock Analysis

When running Glaukos Corp's price analysis, check to measure Glaukos Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Glaukos Corp is operating at the current time. Most of Glaukos Corp's value examination focuses on studying past and present price action to predict the probability of Glaukos Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Glaukos Corp's price. Additionally, you may evaluate how the addition of Glaukos Corp to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC